Dr. Amy Plint graduated from McMaster Medical School, Hamilton in 1991 and completed a pediatrics residency at the University of Manitoba in 1995. She completed a Pediatric Emergency Medicine Fellowship at the University of Ottawa in 1996 and a Master’s Degree in Epidemiology in 2006.
Dr. Plint is the Faculty Medicine Research Chair in Pediatric Emergency Medicine at the University of Ottawa. She is also the Chair of Pediatric Emergency Research Canada (PERC), a well-established multi-centre network of health researchers. Dr. Plint’s research focuses primarily on the emergency department management of respiratory illnesses and musculoskeletal injuries.
Canadian Anaphylaxis Network- Predicting Recurrence after Emergency Presentation for Allergic REaction (CAN-PREPARE): A Prospective, Cohort Study Protocol
Management of pediatric allergic reaction: Practice patterns of Canadian pediatric emergency physicians
Most respondents recognized cases of anaphylaxis; however, a substantial number demonstrated gaps in management that may adversely impact this vulnerable population. The recognition of anaphylaxis without urticaria or pulmonary findings and treatment of anaphylaxis with epinephrine, where indicated, were the main gaps identified.
Exploring Opportunities to improve patient safety in our Emergency Departments
The study explored opportunities to improve patient safety by providing evidence of where to focus efforts in a resource-restricted environment.
Adverse events in the paediatric emergency department: a prospective cohort study
Conclusion One in 40 children suffered adverse events related to ED care. A high proportion of events were preventable. Management and diagnostic issues warrant further study.
Pharmacotherapy in bronchiolitis at discharge from emergency departments within the Pediatric Emergency Research Networks: a retrospective analysis
Use of ineffective medications in infants with bronchiolitis at discharge from emergency departments is common, with large differences in prescribing practices between countries and emergency departments. Enhanced knowledge translation and deprescribing efforts are needed to optimise and unify the management of bronchiolitis.